期刊文献+

CD109的生物学功能及其与乳腺癌的关系 被引量:2

Biological function of CD109 and its relationship with breast cancer
原文传递
导出
摘要 CD109是细胞的一种表面抗原,通过TGF-β信号通路传导来调控细胞的增殖与分化,CD109还同时参与JAK-STAT和表皮生长因子受体(EGFR)信号通路调节细胞增殖与分化功能,与一些疾病及肿瘤的发生与发展密切相关。近年来研究发现CD109在基底细胞样乳腺癌中呈明显高表达,并且与基底细胞样乳腺癌易复发及转移相关,导致治疗和预后效果差。因此CD109检测分析对乳腺癌的诊断及治疗具有重要意义,CD109与乳腺癌的关系成为当前研究的热点。本文综述了CD109的生物学功能及CD109与乳腺癌的关系。 CD109 is a cell surface antigen that regulates cell proliferation and differentiation by negatively regulating TGF-β signaling pathway. It also participates in JAK-STAT and EGFR signaling pathways to regulate cell functions of proliferation and differentiation. It is closely related to the occurrence and development of some diseases and malignant tumors. In recent years, the CD109 has been found to be highly expressed in basal-like breast cancer. The treatment is not satisfying because of the recurrence and metastasis of the basal-like breast cancer. Thus the detection and analysis of CD109 on tumors is very important for the diagnosis and treatment of breast cancer, and the relationship between CD109 and breast cancer has become a hot topic of current research. This review focuses on the biological functions of CD109 and the relationship between CD109 and breast cancer.
作者 张亚男 宋娜 徐丽 张学东 韩冬 李荣贵 韩发彬 Zhang Yanan;Song Na;Xu Li;Zhang Xuedong;Han Dong;Li Ronggui;Han Fabin(College of Life Sciences, Qingdao University, Qingdao 266071, China;The Institute for Tissue Engineering and Regenerative, Liaocheng University/Liaocheng People's Hospital, Liaocheng 252000, China;Shandong Meijia Sai Pei Biotechnology Co., Ltd. Jinan 250101, China)
出处 《中华细胞与干细胞杂志(电子版)》 2019年第3期182-187,共6页 Chinese Journal of Cell and Stem Cell(Electronic Edition)
基金 山东省自然科学基金(ZR2019PC017)
关键词 CD109 信号通路 乳腺癌 细胞增殖 细胞分化 CD109 Signaling pathway Breast cancer Cell proliferation,cell differentiation
  • 相关文献

参考文献3

二级参考文献54

  • 1付琼,姚根有,阮俊,胡云琴.转化生长因子β1和雌激素调节蛋白PS2在乳腺癌中的表达及其对预后的意义[J].实用肿瘤杂志,2006,21(2):155-158. 被引量:4
  • 2张静敏,金宁一,连海,李霄,金毅,安汝国,高桥雅英.实时荧光定量PCR方法检测人正常组织及癌组织中CD109蛋白的表达[J].免疫学杂志,2006,22(6):626-628. 被引量:7
  • 3Livasy CA, Karaca G, Nanda R, et al. Phenotypie evaluation of the basal-like subtype of invasive breast carcinoma [ J ]. Mod Patho1,2006,19 ( 2 ) : 264 - 271. 被引量:1
  • 4Zarcone M, Amodio R, Campi I, et al. Appiication of a new classification to a breast cancer registry: demographic, clinical, and prognostic features of incident cases, Palermo Province, 2002-2004[J]. Ann N YAcad Sci,2009, 1155:222 - 226. 被引量:1
  • 5Anders CK, Fan C, Parker JS, et al. Breast carcinomas arising at a young age : unique biology or a surrogate for aggressive intrin- sic subtypes? [ J/OL ]. J Clin Oncol, 2011, 29 ( 1 ) [ 2012-04- 12 ]. http ://jco. ascopubs, org/content/29/1/elS, full. pdf + ht- ml. 被引量:1
  • 6Hockla A, Radisky DC, Radisky ES. Mesotrypsin promotes ma- lignant growth of breast cancer cells through shedding of CDI09 [ J]. Breast Cancer Res Treat,2010,124 ( 1 ) :27 - 38. 被引量:1
  • 7I-Iasegawa M, Hagiwara S, Sato T, et al. CD109, a new marker for myoep-ithelial ceils of mammary, salivary, and lacrimal glands and prostate basal ceils [ J ]. Pathol Int, 2007,57 ( 5 ) : 245 - 250. 被引量:1
  • 8Hasegawa M, Moritani S, Murakumo Y, et al. CDI09 expression in basal-like breast carcinoma I J ]. Pathol Int, 2008, 58 ( 5 ) : 288 - 294. 被引量:1
  • 9Mehta R, Jain RK, Sneige N, et al. Expression of high-molecu- lar-weigh cytokeratin(34betaE12) is an independent predictor of disease-free survival in patients with triple-negative tumours of the breast [ J ]. Clin Pathol,2010,63 ( 8 ) : 744 - 777. 被引量:1
  • 10Sethi S, Macoska J, Chen W,et al. Molecular signature of epi- thelial-mesenchymal transition (EMT) in human prostate cancer bone metastasis [ J 1. Am J Transl Res, 2010,3 ( 1 ) :90 - 99. 被引量:1

共引文献9

同被引文献17

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部